arrow
P

Peng Liang

harbin medical university cancer hospital
H指数:14
被引数:700

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts

MET抑制剂卡马替尼通过抑制非小细胞肺癌中的MET/Akt/snail信号和减少癌症相关成纤维细胞的生成来克服奥希替尼耐药性

2021-02-1723
OAAI